Works by Nagao, Shoji


Results: 43
    1
    2
    3
    4

    Quality of life assessment of cell‐free and concentrated ascites reinfusion therapy during initial treatment for advanced ovarian cancer: A prospective cohort study.

    Published in:
    Journal of Obstetrics & Gynaecology Research, 2021, v. 47, n. 4, p. 1536, doi. 10.1111/jog.14670
    By:
    • Yamamoto, Kasumi;
    • Nagao, Shoji;
    • Tsu, Tomoharu;
    • Matsushima, Taeko;
    • Ishido, Yoshimi;
    • Narita, Moyu;
    • Suzuki, Kazuhiro;
    • Nakazawa, Hiroshi;
    • Shibutani, Takashi;
    • Jimi, Tomoatsu;
    • Yano, Hiroko;
    • Kitai, Miho;
    • Shiozaki, Takaya;
    • Matsuoka, Kazuko;
    • Yamaguchi, Satoshi
    Publication type:
    Article
    5
    6
    7

    What is an appropriate second-line regimen for recurrent endometrial cancer? Ancillary analysis of the SGSG012/GOTIC004/Intergroup study.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 2, p. 335, doi. 10.1007/s00280-015-2793-9
    By:
    • Nagao, Shoji;
    • Nishio, Shin;
    • Okada, Satoshi;
    • Otsuki, Takeo;
    • Fujiwara, Kiyoshi;
    • Tanabe, Hiroshi;
    • Takano, Masashi;
    • Hasumi, Yoko;
    • Takei, Yuji;
    • Hasegawa, Tetsuya;
    • Matsumoto, Takashi;
    • Fujiwara, Keiichi;
    • Takekuma, Munetaka;
    • Nakamura, Kazuto;
    • Shimada, Muneaki;
    • Suzuki, Mitsuaki;
    • Kigawa, Junzo
    Publication type:
    Article
    8
    9
    10

    Dose-dense paclitaxel and carboplatin vs. conventional paclitaxel and carboplatin as neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: a retrospective study.

    Published in:
    International Journal of Clinical Oncology, 2020, v. 25, n. 3, p. 502, doi. 10.1007/s10147-019-01567-y
    By:
    • Shibutani, Takashi;
    • Nagao, Shoji;
    • Suzuki, Kazuhiro;
    • Kaneda, Michiko;
    • Yamamoto, Kasumi;
    • Jimi, Tomoatsu;
    • Yano, Hiroko;
    • Kitai, Miho;
    • Shiozaki, Takaya;
    • Matsuoka, Kazuko;
    • Sudo, Tamotsu;
    • Yamaguchi, Satoshi
    Publication type:
    Article
    11
    12

    A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study).

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1284, doi. 10.1007/s10147-019-01471-5
    By:
    • Fujiwara, Hiroyuki;
    • Ushijima, Kimio;
    • Nagao, Shoji;
    • Takei, Yuji;
    • Shimada, Muneaki;
    • Takano, Masashi;
    • Yoshino, Kiyoshi;
    • Kawano, Yoshiaki;
    • Hirashima, Yasuyuki;
    • Nagase, Satoru;
    • Nishio, Shin;
    • Nishikawa, Tadaaki;
    • Ito, Kimihiko;
    • Shoji, Tadahiro;
    • Kimura, Eizo;
    • Takano, Tadao;
    • Sugiyama, Toru;
    • Kigawa, Junzo;
    • Fujiwara, Keiichi;
    • Suzuki, Mitsuaki
    Publication type:
    Article
    13
    14

    Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 edition.

    Published in:
    International Journal of Clinical Oncology, 2010, v. 15, n. 2, p. 117, doi. 10.1007/s10147-010-0061-x
    By:
    • Nagase, Satoru;
    • Inoue, Yoshiki;
    • Umesaki, Naohiko;
    • Aoki, Daisuke;
    • Ueda, Masatsugu;
    • Sakamoto, Hideki;
    • Kobayashi, Shigemitsu;
    • Kitagawa, Ryo;
    • Toita, Takafumi;
    • Nagao, Shoji;
    • Hasegawa, Kiyoshi;
    • Fukasawa, Ichio;
    • Fujiwara, Keiichi;
    • Watanabe, Yoh;
    • Ito, Kiyoshi;
    • Niikura, Hitoshi;
    • Iwasaka, Tsuyoshi;
    • Ochiai, Kazunori;
    • Katabuchi, Hidetaka;
    • Kamura, Toshiharu
    Publication type:
    Article
    15
    16

    Incidence and risk factors for venous thromboembolism in gynecological cancer: the GOTIC-VTE trial: Incidence and risk factors for venous thromboembolism in gynecological cancer: the GOTIC-VTE trial: Y. Takahashi et al.

    Published in:
    Journal of Thrombosis & Thrombolysis, 2025, v. 58, n. 2, p. 299, doi. 10.1007/s11239-024-03055-1
    By:
    • Takahashi, Yoshifumi;
    • Fujiwara, Hiroyuki;
    • Yamamoto, Kouji;
    • Yamaguchi, Satoshi;
    • Nagao, Shoji;
    • Takano, Masashi;
    • Miyamoto, Morikazu;
    • Hasegawa, Kosei;
    • Miwa, Maiko;
    • Yasuoka, Toshiaki;
    • Yamashita, Soichi;
    • Hirakawa, Takashi;
    • Nagai, Tomonori;
    • Hamada, Yoshinobu;
    • Uno, Masaya;
    • Mori-Uchino, Mayuyo;
    • Ohwada, Michitaka;
    • Mitsuhashi, Akira;
    • Satoh, Toyomi;
    • Fujiwara, Keiichi
    Publication type:
    Article
    17
    18
    19
    20

    A Randomized Phase II/III Trial of 3 Weekly Intraperitoneal versus Intravenous Carboplatin in Combination with Intravenous Weekly Dose-dense Paclitaxel for Newly Diagnosed Ovarian, Fallopian Tube and Primary Peritoneal Cancer.

    Published in:
    Japanese Journal of Clinical Oncology, 2011, v. 41, n. 2, p. 278, doi. 10.1093/jjco/hyq182
    By:
    • Fujiwara, Keiichi;
    • Aotani, Eriko;
    • Hamano, Tetsutaro;
    • Nagao, Shoji;
    • Yoshikawa, Hiroyuki;
    • Sugiyama, Toru;
    • Kigawa, Junzo;
    • Aoki, Daisuke;
    • Katsumata, Noriyuki;
    • Takeuchi, Masahiro;
    • Suzuki, Mitsuaki
    Publication type:
    Article
    21
    22
    23

    Propensity score-matched analysis of systemic chemotherapy versus salvage hysterectomy for persistent cervical cancer after definitive radiotherapy/concurrent chemoradiotherapy.

    Published in:
    2020
    By:
    • Takekuma, Munetaka;
    • Takahashi, Fumiaki;
    • Mabuchi, Seiji;
    • Kudaka, Wataru;
    • Horie, Koji;
    • Ikeda, Mariko;
    • Shikama, Ayumi;
    • Mitsuhashi, Akira;
    • Nagao, Shoji;
    • Suzuki, Shiro;
    • Mizuno, Mika;
    • Nishio, Shin;
    • Tokunaga, Hideki;
    • Ota, Yukinobu;
    • Kasamatsu, Takahiro;
    • Kitagawa, Ryo;
    • Toita, Takafumi;
    • Kobayashi, Hiroaki;
    • Ishikawa, Mitsuya;
    • Yaegashi, Nobuo
    Publication type:
    journal article
    24
    25
    26

    Re-administration of platinum-based chemotherapy for recurrent endometrial cancer: an ancillary analysis of the SGSG-012/GOTIC-004/Intergroup study.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 10, p. 1594, doi. 10.1007/s10147-024-02585-1
    By:
    • Nagao, Shoji;
    • Nishio, Shin;
    • Takehara, Kazuhiro;
    • Sato, Shinya;
    • Satoh, Toyomi;
    • Shimada, Muneaki;
    • Yamaguchi, Satoshi;
    • Tanabe, Hiroshi;
    • Takano, Masashi;
    • Horie, Kouji;
    • Takei, Yuji;
    • Imai, Yuichi;
    • Hibino, Yumi;
    • Hasegawa, Kosei;
    • Takekuma, Munetaka;
    • Nakamura, Kazuto;
    • Takano, Hirokuni;
    • Fujiwara, Keiichi;
    • Masuyama, Hisashi
    Publication type:
    Article
    27
    28
    29

    Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 1, p. 163, doi. 10.1007/s10147-022-02258-x
    By:
    • Mizuno, Mika;
    • Ito, Kimihiko;
    • Nakai, Hidekatsu;
    • Kato, Hidenori;
    • Kamiura, Shoji;
    • Ushijima, Kimio;
    • Nagao, Shoji;
    • Takano, Hirokuni;
    • Okadome, Masao;
    • Takekuma, Munetaka;
    • Tokunaga, Hideki;
    • Nagase, Satoru;
    • Aoki, Daisuke;
    • Coleman, Robert L.;
    • Nishimura, Yasuko;
    • Ratajczak, Christine K.;
    • Hashiba, Hideyuki;
    • Xiong, Hao;
    • Katsumata, Noriyuki;
    • Enomoto, Takayuki
    Publication type:
    Article
    30
    31

    Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 7, p. 1336, doi. 10.1007/s10147-021-01914-y
    By:
    • Miyagi, Etsuko;
    • Arakawa, Noriaki;
    • Sakamaki, Kentaro;
    • Yokota, Naho Ruiz;
    • Yamanaka, Takeharu;
    • Yamada, Yuki;
    • Yamaguchi, Satoshi;
    • Nagao, Shoji;
    • Hirashima, Yasuyuki;
    • Kasamatsu, Yuka;
    • Kato, Hisamori;
    • Mogami, Tae;
    • Miyagi, Yohei;
    • Kobayashi, Hiroshi
    Publication type:
    Article
    32
    33
    34

    Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations.

    Published in:
    JAMA Network Open, 2024, v. 7, n. 4, p. e245552, doi. 10.1001/jamanetworkopen.2024.5552
    By:
    • Schouten, Philip C.;
    • Schmidt, Sandra;
    • Becker, Kerstin;
    • Thiele, Holger;
    • Nürnberg, Peter;
    • Richters, Lisa;
    • Ernst, Corinna;
    • Treilleux, Isabelle;
    • Medioni, Jacques;
    • Heitz, Florian;
    • Pisano, Carmela;
    • Garcia, Yolanda;
    • Petru, Edgar;
    • Hietanen, Sakari;
    • Colombo, Nicoletta;
    • Vergote, Ignace;
    • Nagao, Shoji;
    • Linn, Sabine C.;
    • Pujade-Lauraine, Eric;
    • Ray-Coquard, Isabelle
    Publication type:
    Article
    35
    36
    37
    38
    39
    40

    Niraparib in Japanese patients with platinum-sensitive recurrent ovarian cancer: final results of a multicenter phase 2 study.

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e115
    By:
    • Hiroaki Itamochi;
    • Nobuhiro Takeshima;
    • Junzo Hamanishi;
    • Kosei Hasegawa;
    • Motoki Matsuura;
    • Kiyonori Miura;
    • Shoji Nagao;
    • Hidekatsu Nakai;
    • Naotake Tanaka;
    • Hideki Tokunaga;
    • Shin Nishio;
    • Hidemichi Watari;
    • Yoshihito Yokoyama;
    • Yoichi Kase;
    • Shuuji Sumino;
    • Ai Kato;
    • Ajit Suri;
    • Toshiaki Yasuoka;
    • Kazuhiro Takehara
    Publication type:
    Article
    41

    Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial.

    Published in:
    Journal of Gynecologic Oncology, 2021, v. 32, n. 5, p. 1, doi. 10.3802/jgo.2021.32.e82
    By:
    • Keiichi Fujiwara;
    • Hiroyuki Fujiwara;
    • Hiroyuki Yoshida;
    • Toyomi Satoh;
    • Kan Yonemori;
    • Shoji Nagao;
    • Takashi Matsumoto;
    • Hiroaki Kobayashi;
    • Bourgeois, Hughes;
    • Harter, Philipp;
    • Mosconi, Anna Maria;
    • Vazquez, Isabel Palacio;
    • Reinthaller, Alexander;
    • Tomoko Fujita;
    • Rowe, Philip;
    • Pujade-Lauraine, Eric;
    • Ray-Coquard, Isabelle
    Publication type:
    Article
    42

    Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer.

    Published in:
    Journal of Gynecologic Oncology, 2021, v. 32, n. 2, p. 1, doi. 10.3802/jgo.2021.32.e21
    By:
    • Kazuhiro Takehara;
    • Takashi Matsumoto;
    • Junzo Hamanishi;
    • Kosei Hasegawa;
    • Motoki Matsuura;
    • Kiyonori Miura;
    • Shoji Nagao;
    • Hidekatsu Nakai;
    • Naotake Tanaka;
    • Hideki Tokunaga;
    • Kimio Ushijima;
    • Hidemichi Watari;
    • Yoshihito Yokoyama;
    • Yoichi Kase;
    • Shuuji Sumino;
    • Suri, Ajit;
    • Hiroaki Itamochi;
    • Nobuhiro Takeshima
    Publication type:
    Article
    43